Pharmacologic activity bepafant WEB new selective hetrazepinoic antagonist platelet factor hetrazepine WEB international nonproprietary name bepafant thieno-triazolodiazepine platelet factor PAF antagonist WEB potent selective PAF antagonist vitro vivo WEB PAF-induced human platelet neutrophil aggregation vitro values microM little inhibitory action aggregation agonists potency vitro comparable WEB Casals-Stenzel Muacevic Weber K.H Pharmacol Exp Ther guinea pigs i.v infusions PAF ng oral mg/kg intravenous mg/kg treatment WEB intrathoracic accumulation platelets bronchoconstriction hypotension death dose-dependent fashion Oral mg/kg intravenous mg/kg beta agonist fenoterol steroid dexamethasone property elderly NMRI mice lethal effect PAF anesthetized rats intravenous mg/kg oral mg/kg inhibited PAF-induced hypotension dose-related manner Coadministration WEB PAF-induced increase vascular permeability rat skin half-time duration action rat oral administration intravenous application conclusion hetrazepine WEB strong selective PAF antagonist vitro equipotent contrast vivo oral WEB species parameter times potent exogenous PAF-induced alterations hetrazepine WEB mice rats oral WEB superior 